The endocannabinoid system consists mainly of 2-arachidonoylglycerol and anandamide, as well as cannabinoid receptor type 1 and type 2 (CB2). Based on previous studies, we hypothesized that a circulating peptide previously identified as osteogenic growth peptide (OGP) maintains a bone-protective CB2 tone. We tested OGP activity in mouse models and cells, and in human osteoblasts. We show that the OGP effects on osteoblast proliferation, osteoclastogenesis, and macrophage inflammation in vitro, as well as rescue of ovariectomy-induced bone loss and prevention of ear edema in vivo are all abrogated by genetic or pharmacological ablation of CB2. We also demonstrate that OGP binds at CB2 and may act as both an agonist and positive allosteric modulator in the presence of other lipophilic agonists. In premenopausal women, OGP circulating levels significantly decline with age. In adult mice, exogenous administration of OGP completely prevented age-related bone loss. Our findings suggest that OGP attenuates age-related bone loss by maintaining a skeletal CB2 tone. Importantly, they also indicate the occurrence of an endogenous peptide that signals via CB2 receptor in health and disease.
Editor's evaluation
By combining pharmacological and mouse genetic genetics strategies the authors show a clear interaction between the cannabinoid receptor CB2 and osteogenic growth peptide (OGP) in the control of bone remodeling and bone mass. They document that OGP attenuates bone loss by maintaining a skeletal CB2 tone, and it does so by allosterically binding to the CB2 receptor. These novel observations should allow further investigations on cannabinoid based strategies for skeletal diseases.
Journal of Health Policy & Management is an open access scholarly periodical that publishes peer-reviewed scientific manuscripts based on update scientific revelations pertaining to multiple aspects of leadership, management and administration of public health systems, health care systems, hospitals and hospital networks. It brings together individual specialties from different fields, notably health management/policy/economics, epidemiology, social/public policy and philosophy into a dynamic academic mix. The journal also focusses on research areas such as Decision Science, Health Economics, Health Care Management and Public Health Policy.
The journal is intended to enhance communication among health system researchers, policy and decision makers, legislators, practitioners, educators, administrators, students, and other types of allied health professionals in the research and healthcare delivery systems. The journal publishes high quality editorials, perspectives, review articles, short communications, case reports, opinion articles, original research articles, policy briefs, commentaries, correspondences, hypotheses and letters to editor.
This peer reviewed journal is using Editorial Manager System for quality in review process. Editorial Manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Health Policy & Management or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through this system.
Articles published in Journal of Health Policy and Management have been cited by esteemed scholars and scientists all around the world. Journal of Health Policy and Management has got h-index 1 , which means every article in Journal of Health Policy and Management has got 1 average citations.
You must be logged in to post a comment.